Literature DB >> 6193764

CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.

S H Koslow, J W Maas, C L Bowden, J M Davis, I Hanin, J Javaid.   

Abstract

Levels of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) in the CSF, and norepinephrine (NE), epinephrine (E), vanillylmandelic acid, normetanephrine, metanephrine, and MHPG in the urine, were measured in 151 hospitalized patients with affective disorders and in 80 healthy controls following a two-week drug-free period. Unipolar and bipolar depressed subjects differed only in NE and E levels. Compared with controls, depressed subjects had higher CSF MHPG levels, women had higher 5-HIAA levels, and men had lower HVA levels. All urinary metabolites were elevated in depression and mania, with the exception of MHPG. The patterns of NE-E differences discriminated among the forms of affective disorders. These data suggest an imbalance of monoamine transmission in depression, characterized by the hyperactive sympathetic nervous system and adrenal medulla. However, MHPG may not be the measure of choice to reflect this imbalance, necessitating measurement of total body monoamine output.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193764     DOI: 10.1001/archpsyc.1983.01790080081011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  21 in total

Review 1.  The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems.

Authors:  Adrian J Dunn; Artur H Swiergiel
Journal:  Eur J Pharmacol       Date:  2008-01-26       Impact factor: 4.432

2.  Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.

Authors:  A E Calogero; W T Gallucci; G P Chrousos; P W Gold
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania.

Authors:  Morgane Milienne-Petiot; James P Kesby; Mary Graves; Jordy van Enkhuizen; Svetlana Semenova; Arpi Minassian; Athina Markou; Mark A Geyer; Jared W Young
Journal:  Neuropharmacology       Date:  2016-10-11       Impact factor: 5.250

4.  Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.

Authors:  B Scatton; H Loo; T Dennis; C Benkelfat; C Gay; M F Poirier-Littre
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 5.  Distinctions between bipolar and unipolar depression.

Authors:  Amy K Cuellar; Sheri L Johnson; Ray Winters
Journal:  Clin Psychol Rev       Date:  2005-05

6.  MHPG excretion in endogenous depression: relationship to clinical state and the effects of ECT.

Authors:  M H Joseph; D Risby; T J Crow; J F Deakin; E C Johnstone; P Lawler
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Association of the physiological stress response with depressive symptoms in patients with breast cancer.

Authors:  Salene M Wu; Hae-Chung Yang; Julian F Thayer; Barbara L Andersen
Journal:  Psychosom Med       Date:  2014-05       Impact factor: 4.312

8.  Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons.

Authors:  G A Ricaurte; U D McCann
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

9.  Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia.

Authors:  M Maes; B Minner; E Suy; C Vandervorst; J Raus
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 10.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.